Cargando…

Power and sample size determination for the group comparison of patient-reported outcomes using the Rasch model: impact of a misspecification of the parameters

BACKGROUND: Patient-reported outcomes (PRO) are important as endpoints in clinical trials and epidemiological studies. Guidelines for the development of PRO instruments and analysis of PRO data have emphasized the need to report methods used for sample size planning. The Raschpower procedure has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanchin, Myriam, Guilleux, Alice, Perrot, Bastien, Bonnaud-Antignac, Angélique, Hardouin, Jean-Benoit, Sébille, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373307/
https://www.ncbi.nlm.nih.gov/pubmed/25880670
http://dx.doi.org/10.1186/s12874-015-0011-4
_version_ 1782363319423729664
author Blanchin, Myriam
Guilleux, Alice
Perrot, Bastien
Bonnaud-Antignac, Angélique
Hardouin, Jean-Benoit
Sébille, Véronique
author_facet Blanchin, Myriam
Guilleux, Alice
Perrot, Bastien
Bonnaud-Antignac, Angélique
Hardouin, Jean-Benoit
Sébille, Véronique
author_sort Blanchin, Myriam
collection PubMed
description BACKGROUND: Patient-reported outcomes (PRO) are important as endpoints in clinical trials and epidemiological studies. Guidelines for the development of PRO instruments and analysis of PRO data have emphasized the need to report methods used for sample size planning. The Raschpower procedure has been proposed for sample size and power determination for the comparison of PROs in cross-sectional studies comparing two groups of patients when an item reponse model, the Rasch model, is intended to be used for analysis. The power determination of the test of the group effect using Raschpower requires several parameters to be fixed at the planning stage including the item parameters and the variance of the latent variable. Wrong choices regarding these parameters can impact the expected power and the planned sample size to a greater or lesser extent depending on the magnitude of the erroneous assumptions. METHODS: The impact of a misspecification of the variance of the latent variable or of the item parameters on the determination of the power using the Raschpower procedure was investigated through the comparison of the estimations of the power in different situations. RESULTS: The power of the test of the group effect estimated with Raschpower remains stable or shows a very little decrease whatever the values of the item parameters. For most of the cases, the estimated power decreases when the variance of the latent trait increases. As a consequence, an underestimation of this variance will lead to an overestimation of the power of the group effect. CONCLUSION: A misspecification of the item difficulties regarding their overall pattern or their dispersion seems to have no or very little impact on the power of the test of the group effect. In contrast, a misspecification of the variance of the latent variable can have a strong impact as an underestimation of the variance will lead in some cases to an overestimation of the power at the design stage and may result in an underpowered study. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-015-0011-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4373307
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43733072015-03-26 Power and sample size determination for the group comparison of patient-reported outcomes using the Rasch model: impact of a misspecification of the parameters Blanchin, Myriam Guilleux, Alice Perrot, Bastien Bonnaud-Antignac, Angélique Hardouin, Jean-Benoit Sébille, Véronique BMC Med Res Methodol Research Article BACKGROUND: Patient-reported outcomes (PRO) are important as endpoints in clinical trials and epidemiological studies. Guidelines for the development of PRO instruments and analysis of PRO data have emphasized the need to report methods used for sample size planning. The Raschpower procedure has been proposed for sample size and power determination for the comparison of PROs in cross-sectional studies comparing two groups of patients when an item reponse model, the Rasch model, is intended to be used for analysis. The power determination of the test of the group effect using Raschpower requires several parameters to be fixed at the planning stage including the item parameters and the variance of the latent variable. Wrong choices regarding these parameters can impact the expected power and the planned sample size to a greater or lesser extent depending on the magnitude of the erroneous assumptions. METHODS: The impact of a misspecification of the variance of the latent variable or of the item parameters on the determination of the power using the Raschpower procedure was investigated through the comparison of the estimations of the power in different situations. RESULTS: The power of the test of the group effect estimated with Raschpower remains stable or shows a very little decrease whatever the values of the item parameters. For most of the cases, the estimated power decreases when the variance of the latent trait increases. As a consequence, an underestimation of this variance will lead to an overestimation of the power of the group effect. CONCLUSION: A misspecification of the item difficulties regarding their overall pattern or their dispersion seems to have no or very little impact on the power of the test of the group effect. In contrast, a misspecification of the variance of the latent variable can have a strong impact as an underestimation of the variance will lead in some cases to an overestimation of the power at the design stage and may result in an underpowered study. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-015-0011-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-15 /pmc/articles/PMC4373307/ /pubmed/25880670 http://dx.doi.org/10.1186/s12874-015-0011-4 Text en © Blanchin et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Blanchin, Myriam
Guilleux, Alice
Perrot, Bastien
Bonnaud-Antignac, Angélique
Hardouin, Jean-Benoit
Sébille, Véronique
Power and sample size determination for the group comparison of patient-reported outcomes using the Rasch model: impact of a misspecification of the parameters
title Power and sample size determination for the group comparison of patient-reported outcomes using the Rasch model: impact of a misspecification of the parameters
title_full Power and sample size determination for the group comparison of patient-reported outcomes using the Rasch model: impact of a misspecification of the parameters
title_fullStr Power and sample size determination for the group comparison of patient-reported outcomes using the Rasch model: impact of a misspecification of the parameters
title_full_unstemmed Power and sample size determination for the group comparison of patient-reported outcomes using the Rasch model: impact of a misspecification of the parameters
title_short Power and sample size determination for the group comparison of patient-reported outcomes using the Rasch model: impact of a misspecification of the parameters
title_sort power and sample size determination for the group comparison of patient-reported outcomes using the rasch model: impact of a misspecification of the parameters
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373307/
https://www.ncbi.nlm.nih.gov/pubmed/25880670
http://dx.doi.org/10.1186/s12874-015-0011-4
work_keys_str_mv AT blanchinmyriam powerandsamplesizedeterminationforthegroupcomparisonofpatientreportedoutcomesusingtheraschmodelimpactofamisspecificationoftheparameters
AT guilleuxalice powerandsamplesizedeterminationforthegroupcomparisonofpatientreportedoutcomesusingtheraschmodelimpactofamisspecificationoftheparameters
AT perrotbastien powerandsamplesizedeterminationforthegroupcomparisonofpatientreportedoutcomesusingtheraschmodelimpactofamisspecificationoftheparameters
AT bonnaudantignacangelique powerandsamplesizedeterminationforthegroupcomparisonofpatientreportedoutcomesusingtheraschmodelimpactofamisspecificationoftheparameters
AT hardouinjeanbenoit powerandsamplesizedeterminationforthegroupcomparisonofpatientreportedoutcomesusingtheraschmodelimpactofamisspecificationoftheparameters
AT sebilleveronique powerandsamplesizedeterminationforthegroupcomparisonofpatientreportedoutcomesusingtheraschmodelimpactofamisspecificationoftheparameters